Suppr超能文献

急性制备的大鼠中β-肾上腺素能受体阻滞剂抗缺血性心律失常的抗心律失常特性的潜在机制。

Mechanisms underlying the antiarrhythmic properties of beta-adrenoceptor blockade against ischaemia-induced arrhythmias in acutely prepared rats.

作者信息

Paletta M J, Abraham S, Beatch G N, Walker M J

机构信息

Department of Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

出版信息

Br J Pharmacol. 1989 Sep;98(1):87-94. doi: 10.1111/j.1476-5381.1989.tb16866.x.

Abstract
  1. The mechanism underlying the limited antiarrhythmic effects of beta-adrenoceptor blocking agents against occlusion-induced arrhythmias in acutely prepared, pentobarbitone-anaesthetized rats has been investigated. 2. Atenolol, ICI 111,581 and propranolol were given at low, medium and high doses calculated to shift dose-response curves to exogenous agonists by factors of 10-30, 100-300 and 1000-3000, respectively. 3. Arrhythmias, blood pressure, heart rate, ECG changes and serum K+ were measured. 4. Antiarrhythmic activity was seen with beta-blocker treatment. This was minimal with atenolol (0.1, 1 and 10 mg kg-1) and only statistically significant with the highest dose of ICI 111,581 (5 mg kg-1), and propranolol (10 mg kg-1). 5. Treatment with beta-adrenoceptor blockers elevated serum potassium concentrations, as compared with saline controls, especially when measured at 30 min post-occlusion. 6. Only ICI 111,581 (5 mg kg-1) and propranolol (1 and 10 mg kg-1) prolonged P-R interval. 7. In order to evaluate possible mechanisms of antiarrhythmic action, attempts were made to correlate antiarrhythmic activity with beta-blockade, serum potassium concentrations, and/or with changes in the P-R interval of the ECG. 8. Reductions in arrhythmias did not correlate well with presumed beta-blockade. Better correlation was obtained with elevations of serum potassium concentration, and with prolongation of P-R interval (a presumed Class I antiarrhythmic action). 9. These results suggested that antiarrhythmic effects of adrenoceptor blocking agents in acutely-prepared anaesthetized rats, subjected to occlusion of a coronary artery, are unrelated to cardiac beta-blockade. The limited antiarrhythmic effects which were observed could be attributed to elevations in serum potassium concentration (due to peripheral beta-blockade) and/or possible Class I antiarrhythmic actions.
摘要
  1. 研究了β-肾上腺素受体阻断剂对急性制备的戊巴比妥麻醉大鼠冠状动脉闭塞诱发心律失常的抗心律失常作用有限的潜在机制。2. 阿替洛尔、ICI 111,581和普萘洛尔分别以低、中、高剂量给药,计算得出这些剂量可使对外源性激动剂的剂量反应曲线分别右移10 - 30倍、100 - 300倍和1000 - 3000倍。3. 测量心律失常、血压、心率、心电图变化和血清钾。4. β受体阻滞剂治疗显示出抗心律失常活性。阿替洛尔(0.1、1和10 mg·kg⁻¹)的这种活性最小,只有ICI 111,581的最高剂量(5 mg·kg⁻¹)和普萘洛尔(10 mg·kg⁻¹)的抗心律失常活性具有统计学意义。5. 与生理盐水对照组相比,β-肾上腺素受体阻滞剂治疗可提高血清钾浓度,尤其是在闭塞后30分钟测量时。6. 只有ICI 111,581(5 mg·kg⁻¹)和普萘洛尔(1和10 mg·kg⁻¹)可延长P-R间期。7. 为了评估抗心律失常作用的可能机制,尝试将抗心律失常活性与β受体阻断、血清钾浓度和/或心电图P-R间期的变化相关联。8. 心律失常的减少与假定的β受体阻断相关性不佳。血清钾浓度升高以及P-R间期延长(假定为I类抗心律失常作用)与之有更好的相关性。9. 这些结果表明,在急性制备的、冠状动脉闭塞的麻醉大鼠中,肾上腺素受体阻断剂的抗心律失常作用与心脏β受体阻断无关。观察到的有限抗心律失常作用可能归因于血清钾浓度升高(由于外周β受体阻断)和/或可能的I类抗心律失常作用。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验